An Interaction between Glutathione and the Capsid Is Required for the Morphogenesis of C-Cluster Enteroviruses

PLoS Pathogens

Volumn 10, Issue 4, 2014, Pages

  Ma, Hsin Chieh ^a   Liu, Ying ^a   Wang, Chunling ^b   Strauss, Michael ^c   Rehage, Nina ^d   Chen, Ying Han ^e,f   Altan Bonnet, Nihal ^e,f   Hogle, James ^c   Wimmer, Eckard ^a   Mueller, Steffen ^a   Paul, Aniko V ^a   Jiang, Ping ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Institute of Epidemiology Helmholtz Centrum   (Germany)

^e RUTGERS UNIVERSITY   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; CESIUM CHLORIDE; GLUTATHIONE; POLIOMYELITIS VACCINE; POLYPROTEIN; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; SULFUR 35; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; CULTURE MEDIUM; ENTEROVIRUS INFECTION; GROWTH CURVE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PLASMID; POLIOMYELITIS VIRUS 1; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEPLETION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SUCROSE DENSITY GRADIENT CENTRIFUGATION; VIRION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS CULTURE; VIRUS INACTIVATION; VIRUS ISOLATION; VIRUS MORPHOGENESIS; VIRUS MUTATION; VIRUS PURIFICATION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSCRIPTION; ANTAGONISTS AND INHIBITORS; ENTEROVIRUS; HELA CELL LINE; METABOLISM; PHYSIOLOGY; VIRUS ASSEMBLY;

CAPSID; ENTEROVIRUS C, HUMAN; ENTEROVIRUS INFECTIONS; GLUTATHIONE; HELA CELLS; HUMANS; VIRUS ASSEMBLY;

EID: 84901359993     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004052     Document Type: Article

References (43)

1. Pompella A, Paolicchi A, Corti A, Franzini M, (2013) Gamma-glutamyltransferase, H2O2-induced apoptosis and expression of catalase. Toxicol In Vitro 27: 991.
2. Griffith OW, Meister A, (1979) Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine). J Biol Chem 254: 7558-7560.
3. Smith AD, Dawson H, (2006) Glutathione is required for efficient production of infectious picornavirus virions. Virology 353: 258-267.
4. Garaci E, Palamara AT, Ciriolo MR, D'Agostini C, Abdel-Latif MS, et al. (1997) Intracellular GSH content and HIV replication in human macrophages. J Leukoc Biol 62: 54-59.
5. Cai J, Chen Y, Seth S, Furukawa S, Compans RW, et al. (2003) Inhibition of influenza infection by glutathione. Free Radic Biol Med 34: 928-936.
6. Palamara AT, Perno CF, Ciriolo MR, Dini L, Balestra E, et al. (1995) Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral Res 27: 237-253.
7. Macchia I, Palamara AT, Bue C, Savini P, Ciriolo M, et al. (1999) Increased replication of Sendai virus in morphine-treated epithelial cells: evidence for the involvement of the intracellular levels of glutathione. Int J Immunopharmacol 21: 185-193.
8. Fenwick ML, Cooper PD, (1962) Early interactions between poliovirus and ERK cells: some observations on the nature and significance of the rejected particles. Virology 18: 212-223.
9. Mikami T, Satoh N, Hatayama I, Nakane A, (2004) Buthionine sulfoximine inhibits cytopathic effect and apoptosis induced by infection with human echovirus 9. Arch Virol 149: 1117-1128.
10. Lonberg-Holm K, Gosser LB, Kauer JC, (1975) Early alteration of poliovirus in infected cells and its specific inhibition. J Gen Virol 27: 329-342.
11. McSharry JJ, Caliguiri LA, Eggers HJ, (1979) Inhibition of uncoating of poliovirus by arildone, a new antiviral drug. Virology 97: 307-315.
12. Geller R, Vignuzzi M, Andino R, Frydman J, (2007) Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev 21: 195-205.
13. Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL, (1988) Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology 166: 265-270.
14. Verlinden Y, Cuconati A, Wimmer E, Rombaut B, (2000) Cell-free synthesis of poliovirus: 14S subunits are the key intermediates in the encapsidation of poliovirus RNA. J Gen Virol 81: 2751-2754.
15. Pfister T, Egger D, Bienz K, (1995) Poliovirus subviral particles associated with progeny RNA in the replication complex. J Gen Virol 76 (Pt 1):: 63-71.
16. Nugent CI, Kirkegaard K, (1995) RNA binding properties of poliovirus subviral particles. J Virol 69: 13-22.
17. Boeye A, Rombaut B, (1992) The proteins of poliovirus. Prog Med Virol 39: 139-166.
18. Wimmer E, Hellen CU, Cao X, (1993) Genetics of poliovirus. Annu Rev Genet 27: 353-436.
19. Rueckert RR (1996) Picornaviridae: the viruses and their replication.; B.N. Fields DMKaPMH, editor. Philadelphia: Philadelphia: Lippincott-Raven.
20. Li C, Wang JC, Taylor MW, Zlotnick A, (2012) In vitro assembly of an empty picornavirus capsid follows a dodecahedral path. J Virol 86: 13062-13069.
21. Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, et al. (2010) Direct interaction between two viral proteins, the nonstructural protein 2C and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog 6: e1001066.
22. Wang C, Jiang P, Sand C, Paul AV, Wimmer E, (2012) Alanine scanning of poliovirus 2CATPase reveals new genetic evidence that capsid protein/2CATPase interactions are essential for morphogenesis. J Virol 86: 9964-9975.
23. Kew OM, Sutter RW, de Gourville EM, Dowdle WR, Pallansch MA, (2005) Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59: 587-635.
24. Nomoto A, Omata T, Toyoda H, Kuge S, Horie H, et al. (1982) Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A 79: 5793-5797.
25. Hogle JM, Chow M, Filman DJ, (1985) Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229: 1358-1365.
26. Butan C, Filman DJ, Hogle JM, (2014) Cryo-Electron Microscopy Reconstruction Shows Poliovirus 135S Particles Poised for Membrane Interaction and RNA Release. J Virol 88: 1758-1770.
27. Pfister T, Wimmer E, (1999) Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J Biol Chem 274: 6992-7001.
28. Putnak JR, Phillips BA, (1981) Picornaviral structure and assembly. Microbiol Rev 45: 287-315.
29. Tian Y, Jiang W, Gao N, Zhang J, Chen W, et al. (2010) Inhibitory effects of glutathione on dengue virus production. Biochem Biophys Res Commun 397: 420-424.
30. Macadam AJ, Ferguson G, Arnold C, Minor PD, (1991) An assembly defect as a result of an attenuating mutation in the capsid proteins of the poliovirus type 3 vaccine strain. J Virol 65: 5225-5231.
31. Putnak JR, Phillips BA, (1981) Differences between poliovirus empty capsids formed in vivo and those formed in vitro: a role for the morphopoietic factor. J Virol 40: 173-183.
32. Phillips BA, Wiemert S, (1978) In vitro assembly of poliovirus. V. Evidence that the self-assembly activity of 14 S particles is independent of extract assembly factor(s) and host proteins. Virology 88: 92-104.
33. Ansardi DC, Porter DC, Morrow CD, (1992) Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J Virol 66: 4556-4563.
34. Marc D, Masson G, Girard M, van der Werf S, (1990) Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J Virol 64: 4099-4107.
35. Moscufo N, Simons J, Chow M, (1991) Myristoylation is important at multiple stages in poliovirus assembly. J Virol 65: 2372-2380.
36. Breindl M, (1971) The structure of heated poliovirus particles. J Gen Virol 11: 147-156.
37. Levy HC, Bostina M, Filman DJ, Hogle JM, (2010) Catching a virus in the act of RNA release: a novel poliovirus uncoating intermediate characterized by cryo-electron microscopy. J Virol 84: 4426-4441.
38. Belnap DM, McDermott BM Jr, Filman DJ, Cheng N, Trus BL, et al. (2000) Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci U S A 97: 73-78.
39. van der Werf S, Bradley J, Wimmer E, Studier FW, Dunn JJ, (1986) Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A 83: 2330-2334.
40. Jiang P, Faase JA, Toyoda H, Paul A, Wimmer E, et al. (2007) Evidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci U S A 104: 9457-9462.
41. Molla A, Paul AV, Wimmer E, (1991) Cell-free, de novo synthesis of poliovirus. Science 254: 1647-1651.
42. Chen Z, Chumakov K, Dragunsky E, Kouiavskaia D, Makiya M, et al. (2011) Chimpanzee-human monoclonal antibodies for treatment of chronic poliovirus excretors and emergency postexposure prophylaxis. J Virol 85: 4354-4362.
43. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612.